Skip to main content

News

Keep up to date with all of the latest company news, press releases and updates.

Pheno Therapeutics granted clinical trial authorisation for lead multiple sclerosis therapeutic candidate PTD802

Pheno Therapeutics granted clinical trial authorisation for lead multiple sclerosis therapeutic candidate PTD802

January 14, 2025
Professor Siddharthan Chandran featured in The Times discussing future prospects for Alzheimer’s patients

Professor Siddharthan Chandran featured in The Times discussing future prospects for Alzheimer’s patients

October 4, 2024
Pheno co-founder Prof Siddharthan Chandran appointed as new director of UK Dementia Research Institute

Pheno co-founder Prof Siddharthan Chandran appointed as new director of UK Dementia Research Institute

October 4, 2023
Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

January 11, 2023
Pheno Co-Founder Prof. Siddharthan Chandran elected to the prestigious Academy of Medical Science Fellowship

Pheno Co-Founder Prof. Siddharthan Chandran elected to the prestigious Academy of Medical Science Fellowship

May 11, 2022
Pheno Therapeutics takes aim at treatments for multiple sclerosis

Pheno Therapeutics takes aim at treatments for multiple sclerosis

February 20, 2020